This test evaluates the mitochondrial function as a measurement

This test evaluates the mitochondrial function as a measurement

of cell viability, which allows the detection of dead cells before they lose their integrity and shape. The amount of viable cells after SLN exposure was performed by the MTT assay with Caco-2 cell models, which are a well-established in vitro model that mimics the intestinal barrier and is often used to assess the Inhibitors,research,lifescience,medical permeability and transport of oral drugs [122]. Other authors have also reported that SLN show biocompatibility, which increase their attractiveness for drug-delivery applications [120]. 6. Marketed Products and Current Studies Since early nineties, researchers turned their attention to lipid nanoparticles because of their nontoxicity and cost/effectiveness relationship [12]. In spite of the advantages, formulating with lipid nanoparticles has been suffering some drawbacks. Because of the GIT conditions, most of promising drugs do not Inhibitors,research,lifescience,medical reach clinical trials. The stability of particles must be comprehensively tested due to pH changes and ionic strength as well as the drug release upon enzymatic degradation Inhibitors,research,lifescience,medical [123]. Lipid nanoparticles absorption through GIT occurs via transcellular (through

M cells or enterocytes) or paracellular (diffusion between cells). If the major drug ZVADFMK uptake occurs through M cells, the portal vein to the liver is bypassed, resulting in higher drug concentrations to the lymph rather than to plasma [124]. Despite the low number of lipid nanoparticles formulations on the market for drug delivery, Mucosolvan retard capsules (Boehringer-Ingelheim) is a story of success [125]. Mucosolvan Inhibitors,research,lifescience,medical retard capsules was the first generation. It was produced Inhibitors,research,lifescience,medical by high-speed stirring of a melted

lipid phase in a hot surfactant solution obtaining an emulsion. This emulsion was then cooled down to room temperature obtaining the so-called “lipid nanopellets for oral administration” [126]. Successful in vivo studies also include rifampicin, isoniazid, and pyrazinamide that are used in tuberculosis treatment. These drugs achieved Cediranib (AZD2171) higher bioavailability when incorporated into SLN compared to the free solutions. Rifampicin has poor cellular penetration which requires high doses to reach effective concentrations. Rifamsolin is a rifampicin-loaded SLN under preclinical phase by AlphaRx. The methodology employed for production is acceptable by the regulatory agencies and has been addressed by various papers and patents [127]. Poor water-soluble drugs, as camptothecin, vinpocetine, and fenofibrate, can have their solubilization improved if incorporated into SLN [124, 128]. Another example is insulin, commonly administered parenterally in the treatment of diabetes mellitus. Injections are often painful and must be administered daily, which result in low patient compliance [129].

Comments are closed.